Paul Burgman

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi A preclinical model for noninvasive imaging of hypoxia-induced gene expression; comparison with an exogenous marker of tumor hypoxia
    Bixiu Wen
    Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, NY, New York 10021, USA
    Eur J Nucl Med Mol Imaging 31:1530-8. 2004
  2. ncbi Cell line-dependent differences in uptake and retention of the hypoxia-selective nuclear imaging agent Cu-ATSM
    Paul Burgman
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Nucl Med Biol 32:623-30. 2005
  3. ncbi Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent mic
    Joseph A O'Donoghue
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Int J Radiat Oncol Biol Phys 61:1493-502. 2005
  4. ncbi Radiosynthesis of [(131)I]IAZGP via nucleophilic substitution and its biological evaluation as a hypoxia marker - is specific activity a factor influencing hypoxia-mapping ability of a hypoxia marker?
    Makiko Suehiro
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Nucl Med Biol 36:477-87. 2009
  5. ncbi The effect of DN (dominant-negative) Ku70 and reoxygenation on hypoxia cell-kill: evidence of hypoxia-induced potentially lethal damage
    Muneyasu Urano
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, NY, USA
    Int J Radiat Biol 88:515-22. 2012
  6. ncbi Detecting changes in tumor hypoxia with carbonic anhydrase IX and pimonidazole
    Kyung Hwan Shin
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Cancer Biol Ther 6:70-5. 2007
  7. ncbi In vivo 19F magnetic resonance spectroscopy and chemical shift imaging of tri-fluoro-nitroimidazole as a potential hypoxia reporter in solid tumors
    Daniel Procissi
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Clin Cancer Res 13:3738-47. 2007
  8. ncbi Hypoxia-inducible factor-1 drives annexin A2 system-mediated perivascular fibrin clearance in oxygen-induced retinopathy in mice
    Bihui Huang
    Department of Cell and Developmental Biology, Weill Cornell Medical College, New York, NY 10065, USA
    Blood 118:2918-29. 2011

Collaborators

Detail Information

Publications8

  1. ncbi A preclinical model for noninvasive imaging of hypoxia-induced gene expression; comparison with an exogenous marker of tumor hypoxia
    Bixiu Wen
    Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, NY, New York 10021, USA
    Eur J Nucl Med Mol Imaging 31:1530-8. 2004
    ....
  2. ncbi Cell line-dependent differences in uptake and retention of the hypoxia-selective nuclear imaging agent Cu-ATSM
    Paul Burgman
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Nucl Med Biol 32:623-30. 2005
    ..In this study, we examined the mechanisms underlying the uptake of (64)Cu in cells incubated with (64)Cu-ATSM...
  3. ncbi Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent mic
    Joseph A O'Donoghue
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Int J Radiat Oncol Biol Phys 61:1493-502. 2005
    ..To compare two potential positron emission tomography (PET) tracers of tumor hypoxia in an animal model...
  4. ncbi Radiosynthesis of [(131)I]IAZGP via nucleophilic substitution and its biological evaluation as a hypoxia marker - is specific activity a factor influencing hypoxia-mapping ability of a hypoxia marker?
    Makiko Suehiro
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Nucl Med Biol 36:477-87. 2009
    ....
  5. ncbi The effect of DN (dominant-negative) Ku70 and reoxygenation on hypoxia cell-kill: evidence of hypoxia-induced potentially lethal damage
    Muneyasu Urano
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, NY, USA
    Int J Radiat Biol 88:515-22. 2012
    ..To study the effect of DN (dominant-negative) Ku70 and reoxygenation on the hypoxia-induced cell-kill...
  6. ncbi Detecting changes in tumor hypoxia with carbonic anhydrase IX and pimonidazole
    Kyung Hwan Shin
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Cancer Biol Ther 6:70-5. 2007
    ..In contrast, in the carbogen group pimonidazole staining decreased to 3% (p = 0.01) though CAIX expression was again unaltered. These results suggest that comparison of CAIX and pimonidazole will allow for the detection of reoxygenation...
  7. ncbi In vivo 19F magnetic resonance spectroscopy and chemical shift imaging of tri-fluoro-nitroimidazole as a potential hypoxia reporter in solid tumors
    Daniel Procissi
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Clin Cancer Res 13:3738-47. 2007
    ....
  8. ncbi Hypoxia-inducible factor-1 drives annexin A2 system-mediated perivascular fibrin clearance in oxygen-induced retinopathy in mice
    Bihui Huang
    Department of Cell and Developmental Biology, Weill Cornell Medical College, New York, NY 10065, USA
    Blood 118:2918-29. 2011
    ..These data suggest new potential approaches to retinal angiogenic disorders on the basis of modulation of perivascular fibrinolysis...